Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBIT (2022 - 2025)

ASP Isotopes has reported EBIT over the past 4 years, most recently at -$25.0 million for Q4 2025.

  • For Q4 2025, EBIT fell 227.14% year-over-year to -$25.0 million; the TTM value through Dec 2025 reached -$59.9 million, down 127.32%, while the annual FY2025 figure was -$59.9 million, 127.32% down from the prior year.
  • EBIT for Q4 2025 was -$25.0 million at ASP Isotopes, down from -$15.0 million in the prior quarter.
  • Over five years, EBIT peaked at -$827959.0 in Q2 2022 and troughed at -$25.0 million in Q4 2025.
  • A 4-year average of -$6.7 million and a median of -$4.9 million in 2023 define the central range for EBIT.
  • Biggest five-year swings in EBIT: crashed 425.09% in 2023 and later tumbled 36.76% in 2025.
  • Year by year, EBIT stood at -$1.5 million in 2022, then plummeted by 175.73% to -$4.0 million in 2023, then plummeted by 90.1% to -$7.6 million in 2024, then tumbled by 227.14% to -$25.0 million in 2025.
  • Business Quant data shows EBIT for ASPI at -$25.0 million in Q4 2025, -$15.0 million in Q3 2025, and -$12.0 million in Q2 2025.